Colorectal cancer is a high disease burden cancer and is the second leading cause of cancer deaths worldwide. The first-line treatment option is surgical resection of cancerous tissue. However, the ...
Korean Society of Coloproctology trial of consolidation chemotherapy for locally advanced mid or low rectal cancer after neoadjuvant concurrent chemoradiotherapy: KONCLUDE multicenter radomized trial.
“Patients may not be aware that they could have a hereditary risk,” explained Al B. Benson, III, MD, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chair of the NCCN ...
Cancer is generally a disease of the aging, but doctors are seeing more cases of early-onset colorectal cancer, and the sharpest increase in metastatic, early-onset colorectal cancer is among people ...
GLP-1 receptor agonist therapy for type 2 diabetes or obesity is associated with a significantly lower risk of developing colon cancer.
Phase II Study of Ipilimumab, Nivolumab, and Panitumumab in Patients With KRAS/NRAS/BRAF Wild-Type Microsatellite Stable Metastatic Colorectal Cancer Neoadjuvant chemotherapy (NAC) is increasingly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results